Cost of diseases in international perspective by Koopmanschap, M.A. (Marc) et al.
EUROPEAN JOURl" iK«amiawwaiaB.iwiMi»M««Kg|gl
Cost of diseases in international perspective
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PAUL J. VAN DER MAAS, THE TECHNOLOGY ASSESSMENT METHODS PROJECT TEAM *
This study compares the health care costs of The Netherlands with the United States and Sweden and estimates the
impact of demographic change on costs. Total health care costs were allocated to disease, age, sex and specific
subsectors. For The Netherlands 75% of the costs in 1988 were assigned to specific diseases. Costs of mental
disorders and other chronic non-fatal diseases dominate, followed by cardiovascular diseases. The effect of age is
strong from age 70 years onwards. The effect of sex, adjusting for age, is small, except for elderly women, who are
more expensive. Both total and disease-specific costs are similar in The Netherlands and Sweden, but differ from those
in the US. The available data suggest that the differences in medical practice and health care systems may explain
a substantial part of the divergent results; demographic or epidemiologic aspects seem less important. Ageing
induces, in the Dutch case, a modest 0.7% annual increase in costs. The contribution of other forces in the increase
of costs is probably more important. A structural upward pressure on costs also prevails in The Netherlands and
Sweden, but it is more prominent in the US, due to a large amount of expensive surgery and high administration costs.
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T he level of medical consumption is determined by
epidemiology, medical practice, economic factors includ-
ing the type of health insurance system and cultural
circumstances. Having stated this, it is surprising that the
recent debate on value for money in various health care
systems focuses largely on aggregate expenditure levels,
paying little attention to the important relation between
disease and medical consumption.1 In this paper the costs
of illness are estimated for The Netherlands, covering the
entire range of diseases and providing data on disease-spe-
cific costs, according to age, sex and health care sector.
Next the level of medical care costs and the distribution
according to disease will be compared with the United
States and Sweden. For some diseases we will indicate
whether die remarkable differences in costs appear to be due
to divergence in demography and epidemiology or whedier
supply and financing of health care are most relevant in
explaining these differences. We cannot provide a complete
analysis for all diseases, as this requires a reliable interna-
tional overview of (longitudinal) morbidity data, which is
currently lacking. Still this paper may contribute to the
debate on the quality and costs of health care.
Another important policy item is estimating the con-
sequences of ageing. It will be shown how rapidly medical
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costs may increase due to demography alone, compared
with the impact of other expenditure increasing factors.
METHODS
Cost of illness in The Netherlands
Total health care costs in The Netherlands, excluding
care in old peoples homes and social work, amounted to
39.8 billion Dutch guilders (ECU 15.9 billion), according
to the national Financial Overview of Health Care.2
These costs were allocated to age, sex, health care sector
and disease categories.3 To this end health care was di-
vided into 18 sectors. All diseases of the International
Classification of Diseases 9-CM4 were assigned to 48
disease categories, using as criteria comprehensive data on
morbidity, mortality, costs and expected developments.
They can be aggregated to the standard 17 ICD-chapters.
The primary diagnosis of patients was used to assign costs
to specific diseases.
Most data were extracted from national registers with
nearly complete coverage. The Dutch hospital registra-
tion system was described by Casparie.5 For some other
sectors we use data from large surveys such as the Dutch
National Health Interview Survey,6 which is comparable
to its US counterpart NHIS. For a few sectors insurance
data were used (table I). The available data on diagnosis
were all registered by the responsible physician or nurse,
conforming to the ICD 9-CM rules. Costs incurred by
dental or maternity services were allocated to dental
diseases and pregnancy and delivery respectively. Infor-
mation on diagnosis was not complete or absent regarding
care for physically handicapped, home help, pharmaceu-
ticals, general preventive care, patient transport and ad-
ministration. They represent 25% of the health care costs.
For each health care sector total costs were assigned to
age, sex and diagnosis by using utilization of services, the
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number of patients or the expenditures per group of pa-
tients (table 1). For example, the number of visits to
physical therapists determines the distribution of costs for
physical therapy, assuming each visit has the same cost.
Regarding hospitals and nursing homes, we used the num-
ber of hospital days; for psychiatric care and care for
mentally or physically handicapped the number of pa-
tients was used to allocate costs. For most ambulatory
services we used the number of visits to attribute costs. In
the case of maternity services, appliances and patient
transport cost allocation were based on expenditures.
Data on age and sex were available for all health services,
except for general preventive care and administration;
considered as indivisible goods, they have been assigned
by assuming equal costs per citizen.
International comparison
The results for The Netherlands will be compared with
Sweden7 and the US.8 All 3 studies use the primary
diagnosis to assign costs to disease categories. The data
used are a mixture of national and regional registrations
and samples and surveys on health care utilization and
costs. In the US study non-personal health costs such as
costs for government public health care and insurers and
government administration were excluded. Costs of pa-
tient transport were not allocated to a specific disease
(table 1). In Sweden, home help is a part of the social
services and was therefore excluded. The costs of dental
care, appliances, patient transport, government public
health care and administration were not assigned to dis-
ease.
The proportion of costs which could be assigned to spe-
cific diseases is similar in the three countries. In Sweden
78% was assigned, in The Netherlands 75% and in the
US 82% (table 2). As detailed cost analyses of the entire
health care system would have been too complicated,
each study used aggregated data on utilization and costs
to assign costs to diagnosis, age and sex. The procedures
used in distributing costs to diagnosis are fairly similar,
with a few exceptions. The US study uses estimates of
Table 1 Overview of methods and data used for allocation of costs to disease categories per health care sector in The Netherlands (NL),
Sweden and the US
Health care service
Hospital
Nursing and
physician services
Surgery
Nursing homes
Psychiatric care
In-patient
Out-patient
Care for mentally
retarded
Care for physically
handicapped
General practitioner
District nursing
Home help
Maternity services
Physical therapy
Dental care
Drugs
Eyeglasses and appliances
Governmental public
health care
Patient transport
Administration (insurers
and government)
% Health care
costs NL
32
3
10
6
2
6
3
5
2
4
1
3
4
9
2
2
1
6
Data on Data type and
diagnosis NL source NL
+ National register
+ National register
+ National register
+ National register
+ National register
+ National register
+ —• Registers and
samples
+ Detailed sample
GP and patients
+ Regional register
— Sample
+ Insurers data
+ Sample
+ Dutch HIS
Dutch HIS
+ Insurers data
+ - Government
department
— Insurers data
— Government and
insurers
Allocation NL
Hospital days
Surgical procedures
and tariffs
Nursing home days
Residents
Clients
Residents
Residents
Visits
Visits
Visits
Expenditures
Visits
Visits
Prescriptions
Expenditures
Equal costs per
person
Expenditures
Equal costs per
person
Allocation Sweden
Hospital days and
cost per day
Out-patient visits
Nursing home days
Expenditures
Expenditures
Expenditures
Not allocated
Visits
Visits
Not allocated c
Expenditures
Visits
Not allocated
Prescriptions and
prices
Not allocated
Not allocated
Not allocated
Not allocated
Allocation US
Hospital days and
expenses per day
Out-patient visits
Surgical procedures
Residents and
monthly expenses
Residents
Psychiatric visits
Residents
Residents
Visits
Hospital days a
Hospital days a
Visits
Hospital days a
Visits
Physician visits
Persons glasses/
hearing aids
Not allocated
Not allocated
Not allocated
+: Information on diagnosis conforming to 1CD 9-CM; + —: Information on diagnosis partially conforming to ICD 9-CM
-: No information on diagnosis available
x Costs were allocated to disease, using the distribution of hospital days
b: Not allocated separately, as they are included in the hospital sector
c: In Sweden home help is not included in health care but in social services
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costs per hospital day by diagnosis category (table 1). In
the Swedish study, costs per hospital day were made
disease-specific, by using cost estimates for several hospital
departments. For The Netherlands, we assumed equal cost
per day for all diseases, as reliable disease-specific data on
the costs per hospital day are currently not available. The
Dutch data on non-hospital care appear to be more com-
plete and reliable. For example, in the US study the costs
of several home health care services had to be assigned to
diseases, using the distribution of hospital days.
Demography and costs
Using the estimated mean costs per person by disease, age
and sex for 1988, we calculated future health care costs,
on the basis of expected demographic development.9 We
used 2030 as the end-point of our predictions, when
ageing of the Dutch population is expected to reach its
maximum. In order to relate the increase in costs to
expected economic growth we used the 'Europe-scenario'
drawn up by The Netherlands Central Planning Bureau,1 °
predicting a 2.8% yearly increase in real GNP.
Table 2 Distribution of direct costs by disease categories (17
chapters of the ICD 9-CM) in the US 1980, Sweden 1983 and
The Netherlands 1988 in percentages of total direct costs
Disease category
(ICD chapters)
Infective diseases
Neoplasms
Endocrine and metabolic
disorders
Diseases of the blood
Mental disorders
Disease of the nervous
system
Cardiovascular diseases
Respiratory diseases
Disease of the digestive
system
Genitourinary diseases
Pregnancy and delivery
Diseases of the skin
Locomotor diseases
Congenital anomalies
Perinatal diseases
Symptoms
Accidents, poisoning and
violence
Other diseases
Not allocated
Total
USa
%
1.8
5.5
3.1
0.4
8.3
7.1
13.6
7.0
12.9
5.1
b
2.5
5.5
0.5
b
1.6
7.7
3.6b
14.2"
100
Sweden
%
1.6
5.1
2.3
0.5
21.1
4.2
12.3
5.0
3.8
3.0
2.7
1.7
3.9
0.5
0.5
5.1
4.8
0.0
21.9
100
The Netherlands
%
1.0
4.6
1.7
0.3
19.9
3.8
8.7
3.1
7.6
2.7
3.5
0.9
7.0
0.4
0.9
4.3
4.3
0.0
25.2
100
a For comparability-, the US percentages derived by Rice8 were corrected for
non-personal health care costs (e-g. insurers and government administration
and government public health services). These costs now make up the lion's
share of unallocated costs
b For the US the costs of pregnancy and perinatal diseases could not be
discerned separately and are mentioned as costs of other diseases
RESULTS
Costs fry disease and sex
In figure 1 we show the costs by 17 disease categories and
sex. Mental disorders (including mental retardation) gen-
erate by far the highest costs, accounting for 20% of total
costs, followed by cardiovascular diseases (9%), disease of
the digestive system (8%, including dental diseases) and
locomotor diseases (7%). The most expensive disease
categories are chronic, non-fatal illnesses. Cardiovascular
diseases and cancer, accounting for 71 % of Dutch mortal-
ity, make up only 14% of the health care costs. Women
account for 57% of total costs, including the costs of
pregnancy. The distribution of costs among ICD-chapters
is quite similar for both sexes. Costs of cardiovascular
disease are relatively more important for men (10 versus
8%), while for women locomotor diseases are relatively
more important (8 versus 6%). Due to the standard regis-
tration procedure, the small amount of pregnancy-related
costs for men are attributable to healthy babies who stay
a short period in hospital, after birth. The results for the
US8 are similar. Rice8 concludes that women account for
59% of health care costs and that the distribution of costs
by disease is not very sex specific.
Costs by disease and age
The pattern of costs of illness related to age is quite
diverse. For the age group 0-19 years, costs of mental
disorders, gastrointestinal diseases (in particular dental care)
and perinatal diseases are the most expensive. In the age
group 20-44 years, costs of mental disorders still domin-
ate, followed by costs of pregnancy, dental diseases and
locomotor diseases. From age 45 to 64 years cardiovascular
disease, locomotor disease and cancer represent the great-
est costs, followed by mental disorders. Costs of cardiovas-
cular disease are the most important in people aged 65-79
years. From age 80 years onwards, the typical impairments
of the most elderly are reflected in high costs for dementia,
stroke, locomotor disease and non-traffic accidents.
Costs try age and sex
Figure 2 presents the mean annual costs per person by age
and sex. These costs rise gradually from dfl 1,000 for age
5-9 years to 3,000 for age 55—59 years. From age 60 years
on, costs accelerate, reaching a maximum of dfl 18,000 for
age 85 years and older. Given their age, differences in costs
between men and women are small, except for the higher
costs for women of age 80 years and older. The causes of
this exception are at least 2-fold: these women are on
average older than men in the same age group and more
often single, which increases their probability of hospital-
ization.11 The higher costs for women aged 20-44 years
are due to pregnancy and childbirth. Our Dutch cost
estimates correspond quite closely to results for the US.
In 1980 the mean costs per US citizen older than 65 years
were 2.75 times the mean for all citizens12; the corres-
ponding Dutch ratio was 2.86 in 1988. Waldo's13 estim-
ates for health care costs by age for the US in 1987 confirm,
this conclusion.
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Disease category
Blood diseases
Congenital diseases
Perinatal diseases
Dis of the skin
Infective dis
Endocrine dis
Urogenital dis
Respiratory dis
Pregnancy
Nervous system
External causes
Symptoms
Neoplasms
Locomotor dis
Digestive dis
Cardiovascular dis
Mental disorders
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Costs in million Dutch guilders
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Figure 1 Costs of health care by disease category and sex for The Netherlands 1988, in million
Dutch guilders
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Figure 2 Mean health care costs per year per person by age and sex for The Netherlands 1988, in thousand
Dutch guilders
International comparison •
Table 2 presents the distribution of health care costs by
ICD-chapters for the US (1980), Sweden (1983) and The
Netherlands (1988). A satisfactory explanation of all
differences requires a systematic analysis of health care
systems, demography and epidemiology, which is beyond
the scope of this study. The main obstacle for a complete
analysis is the lack of reliable, comparable data regarding
disease-specific morbidity. Nevertheless, our partial com-
parison reveals interesting outcomes.
The results for Sweden and The Netherlands are very
similar; the low costs for diseases of the digestive tract in
Sweden are due to the omission of dental care in
Lindgren's^ study. The US pattern of costs deviates on
several points from the two European countries. The low
costs for mental disorders in the US probably do not
reflect a lower prevalence.
Two meta-analyses show no
difference in prevalence
rates of dementia for
Europe14 and the US.15 For
mental retardation evidence
is less firm, but prevalence
estimates for children in the
US and Scandinavia are in
the same range.16>1^ There-
fore, it appears that the low
costs for mental illness in the
US are due to the small ex-
tent of in-patient psychiatric
care: the number of beds per
1,000 citizens in psychiatric
hospitals in The Nether-
lands and Sweden is much
higher than in the US, both
for 1980 and 1989 (table 3).
For cardiovascular disease
comparative morbidity data
are not available, but the
high US costs may be at least
in part related to more sur-
gery, as the relative fre-
quency of coronary artery by-
pass grafting (CABG) in the
US in 1988 was more than
twice the Dutch and Swed-
ish rate (table 3). In addition,
the rate of increase in per-
forming bypasses between
1985 and 1988 for the US
was much larger than for The
Netherlands. The automatic
reimbursement of costs in
the US clearly provides an
economic incentive for in-
creasing the number of
CABGs, whereas in The
Netherlands and Sweden the
number of bypasses is highly
regulated.18 Regarding digestive diseases the story is
analogous: the surgery rate in the US is 16.6 per 1,000
citizens as compared to 9.2 for The Netherlands,19'20
whereas in both countries surgery for digestive diseases
makes up 16% of total surgery.
The substantial costs of accidents, poisoning and violence
in the US are undoubtedly due to their high incidence.
The US mortality rate for traffic accidents involving
passenger cars is twice as high as for The Netherlands and
Sweden. As this cannot be explained by differences in
lethality, it points to higher incidence, caused by the
larger mobility in the United States.21-2^ With respect to
homicide an average US citizen has a 10 times higher risk
of being killed than the average Dutchman, indicating a
much larger incidence of accidents related to violence.23
Turning to total costs, table 3 shows that both the share
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of costs in GNP and the mean costs per capita are sub-
stantially higher in the US. Furthermore, the costs are still
rising in the US while they are stabilizing in The Nether-
lands and Sweden.1' Hence, one may ask: what makes US
health care so expensive?
If a less favourable age composition of the US population
were the cause, standardizing the population of The
Netherlands to that of the US regarding age and sex,2^
combined with actual pro capita costs for The Nether-
lands, it should result in higher projected costs compared
to the actual Dutch costs. However, this calculation gives
almost identical costs, so differences in demography can
be ruled out as an explanation. Moreover, although the
Swedish population is considerably older, Swedish health
care costs are still quite moderate.
Undoubtedly, the high administration costs in the US,
especially within hospitals, play an important role in the
expansion of costs. For the US, they were estimated to be
between 19 and 24% of the total health care costs in
1987.25 Using the same definition with respect to admin-
istration costs for The Netherlands we estimate them to
be 11-14% in 1988 (table 4).
Table 3 Public health and health care iriThe Netherlands, Sweden and the United States
.Item
Epidemiology
Life-expectancy at birth in years
Infant mortality rate per 100,000 live births
Mortality rate for traffic accidents with
passenger cars per 100,000 persons "
Mortality rate for homicide per 100,000
persons
Costs
Health care costs as share in GNP in %
Costs per person US$ PPP
Input
Number of pract physicians per 1,000
inhabitants
Psychiatric care beds per 1,000 inhabitants
Acute care hospital beds per 1,000 inhabitants
Output
Mean length of acute hospital stay
In hospital surgery per 1,000 inhabitants
CABG surgery per million inhabitants
Incomes
Mean earnings per physician US$ PPP
Year/
gender
Male
Female
Male
Female
1987
Male
Female
1988
1990
1990
1988
1980
1989
1988
1988
1988
1985
1988
1988
The
Netherlands
1988
73.7
80.5
1988
798
563
5.23
1988
1.1
.0.7
8.2
8.1
1,182
2.4
1.7
1.6
4.5
11.3
56.8C
480
583
70,00^
Sweden
1987
74.2
80.4
1987
668
553
5.70
1987
1.5
0.9
8.5
8.7
1,421
2.9
3.2
1.8
4.1
7.5
NA
250
464e
48,000
US
1988
71.6
78.6
1988
1099
866
10.63
1988
12.8
4.0
11.4
12.4
2,566
2.3
0.9
0.6
3.7
6.5
105
780
1265
144,700
PPP: purchasing power parities; CABG: coronary artery bypass grafting
Sources: if not indicated by superscript see reference 19
a See reference 21; b see reference 23; c see reference 20; d see reference 18;
e see reference 32; f personal communication
Regarding input, the number of physicians and beds in
acute care hospitals per citizen in the US is slightly smaller
than for The Netherlands and Sweden (table 3), which
cannot explain higher costs. Turning to output, the
length of stay in acute care hospitals in the US is lower
than in The Netherlands and comparable to Sweden,
which would rather point to lower costs. A really striking
difference is the 'high intensity' of US medicine, illus-
trated by the rate of in-patient surgical procedures which
is approximately twice as high for the US as for The
Netherlands (table 3). Studies of pacemaker implanta-
tion,26 endoscopy2^ and carotid endarectomy28 indicate
that overtreatment of insured patients is not exceptional
in the US. The costs of 'defensive medicine' in the US
were estimated to be US $ 15 billion in 1989.29This style
of practising medicine may also be related to the compet-
ition between US hospitals concentrating on 'quality'
rather than on price, resulting in the duplication of ex-
pensive equipment and services. Robinson and Luft30
have shown convincingly that in the US the amount of
medical equipment within each hospital increases with
the number of other hospitals in the neighbourhood. In
The Netherlands, regional
dispersion of expensive serv-
ices is regulated by licensing,
which reduces the inefficient
use of medical equipment.
Comparing prices of health
care services between coun-
tries is not without problems,
but an OECD31 study indic-
ates that for the equivalent of
US $ 1 significantly more
medical services can be
bought in other OECD
countries than in the US.
Viewing the mentioned data
on volumes and prices, it is
not surprising that mean
earnings of physicians in the
US are three times as high as
in Sweden and twice the
Dutch level19 (S. Jendteg,
personal communication)
(table 3). The formidable li-
ability insurance premiums
for US physicians, which
have grown by approxim-
ately 15% per year in recent
years,29 contribute to the rise
in health care costs, al-
though the physician's net
disposable income is not af-
fected.
Demography and costs
For the years 2010 and 2030,
we calculated the con-
sequences for health care
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costs of expected demographic developments in The
Netherlands, using the estimated mean costs per person
by age and sex for 1988. As presented in table 5, total costs
will rise by 1% per year during 1988-2030. Seventy per
cent of this increase (0.7%), is due to ageing, the remain-
ing 0.3% being a result of population growth. During
2010-2030 ageing will be responsible for 90% of the
increase in costs: 0.9% per year. For the period 1980—
2040, Rice32 estimated US health care costs would grow
by 1.1% per year, of which only 0.3% will be caused by
ageing. Diseases for which costs are expected to rise faster
than average are shown in table 5. The forecasts for these
diseases are quite reliable, as they .depend largely on the
life expectancy of the living population and for most of
these diseases the pattern of care and costs is not expected
to change radically. Costs of dementia, lung and prostate
cancer, stroke and heart failure will rise substantially up
to 2010, but will increase more rapidly still in the decades
thereafter, as the Dutch post-War baby boom reaches the
age of 70 at which age medical consumption will acceler-
ate (figure 2).
The 0.7% annual growth of costs due to ageing is quite
modest when compared with expected long term econom-
ic growth: 2.8%. Other forces than ageing seem to be more
important in increasing health care costs. For example, in
the majority of OECD countries, including die US, health
care prices structurally tend to rise faster than in the rest
of the economy.19'33'** In part this is due to lower produc-
tivity growth in health care than in manufacturing indus-
tries, but it also may reflect the improved quality of
medical services. This relative price increase of health
care services acts as a continuous upward pressure on
health care costs. During 1980-1990 health care prices in
the US rose 2.75% more than general inflation and in
Sweden 1.0%, whereas in The Netherlands no difference
occurred.19
DISCUSSION
The international comparability of disease-specific data
has been questioned recently. Stehbens35 demonstrated
Table 4 Administration costs (using Woolandler and
Himmelstein's definition) as % of total health care costs for the
US 1987 and The Netherlands 1988
Expenditure category
The Netherlands
1988
US
1987
Programme administration
and insurance overheada 4.4 5.1
Hospital administration 3.0-5.0 7.8
Nursing home administration 0.8 1.3
Physicians'overhead0 3.5 5.1-9.8
Total 11.7-13.7 19.3-24.1
Sources:
a For the United States (all items), see reference 25;
for The Netherlands the calculation was based on reference 2
b For The Netherlands see reference 42
c For The Nedierlands: personal communication
that diagnostic errors in certified causes of death may
result in unreliable mortality statistics, invoking wrong
conclusions on epidemiologic trends. It is not known
whether the misclassification bias as reported for causes
of death is equally important for diagnosis related to
medical consumption. However, the international com-
parison presented is limited to very broad disease categor-
ies: the 17 ICD-chapters. Although differences in case-
mix between countries within ICD-chapters may be
substantial, misclassification between ICD-chapters ap-
pears to be less likely.
We used only the primary diagnosis of patients to assign
costs to disease. This facilitates the comparison of results
between diseases, a frequent problem in cost of illness
studies, but it may underestimate costs of diseases which
often prevail as co-morbidity, such as diabetes. Reliable
data on co-morbidity and its influence on medical con-
sumption may improve the cost estimates, especially for
elderly people, but at the moment these are not available.
If disease-specific data on pharmaceuticals become avail-
able for The Netherlands, it is unlikely that the ranking
of diseases by costs will change substantially, because
drugs only represent 9% of total healdi care costs in The
Netherlands. Lindgren's7 data for Sweden indicate that,
except for mental diseases, the ranking of total costs and
costs of drugs by disease is quite similar.
The most recent cost estimates for the US date from 1980,
but may still be valid, as comparison of the distribution of
US costs by disease for 1980 and 1972 also showed only
minor differences.8-36 This also holds for die Swedish
results regarding 1975 and 1983.7-37
Although we do not provide a complete analysis of inter-
national differences in health care costs, numerous find-
ings point to more aggressive medical practice, higher
administration costs and higher prices as the main causes
of unparalleled costs in the US. Further research is ur-
gently needed to shed more light on the contribution of
epidemiological causes. However, the high costs in the
US do not seem to produce better health care and public
healdi for the average American citizen. In the US the
amount of care in psychiatric hospitals and nursing homes
is substantially smaller than in The Netherlands and
Table 5 Indices for the predicted development of health care costs
by disease category, due to demography in The Netherlands, for
the years 2010 and 2030 (1988=100)
Disease category Year
2010 2030
All diseases 121 139
Prostate cancer 141 206
Dementia 148 203
Heart failure 143 196
Stroke 140 193
Lung cancer 142 185
Male genital diseases 136 181
Diabetes 134 174
Ischaemic heart diseases 141 174
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Sweden21 (takie 3). Life expectancy at birth is lower in
the US than in The Netherlands and Sweden, while
infant mortality is higher.23 This may be closely related to
the fact that approximately 14% of Americans are unin-
sured. In The Netherlands the number of uninsured is
negligible (0.3-0.5%) and Sweden has a national healdi
care system ensuring universal access to health care. Pre-
ventive care in die US is underdeveloped, resulting in, for
example, low immunization rates for infants.39'40
With respect to the impact of demographic change on
costs we assumed that the relation between age, sex and
health care costs for 1988 is a valid estimate for the future.
In the absence of reliable evidence of the influence of
epidemiology and technology on future medical con-
sumption this estimate provides a reasonable baseline
scenario, to be modified after more detailed research. If,
for example, the health care costs for the elderly increase
relatively more than for the young, our calculations may
underestimate the true costs of ageing. Further research
on the development of the relation between age, morbid-
ity and health care costs is needed to improve these
estimates.
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